BCBS Says Generic Xyrem Delay Was Antitrust Scheme
Blue Cross Blue Shield Association has accused Jazz Pharmaceuticals in California federal court of paying off generic-drug makers to delay their rival versions of the pharmaceutical giant's brand name narcolepsy drug...To view the full article, register now.
Already a subscriber? Click here to view full article